MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, today announced the promotion of Manesh Naidu, MBA, to chief commercial officer. Mr.

新泽西州蒙茅斯交界处（商业新闻）——Tris Pharma，Inc.（Tris），一家专注于注意力缺陷多动障碍（ADHD），疼痛，成瘾和神经系统疾病的商业阶段生物制药公司，今天宣布将MBA Manesh Naidu晋升为首席商务官。先生。

Naidu previously served as the Company’s vice president of marketing..

Naidu曾担任该公司营销副总裁。。

“Manesh is a respected leader and experienced commercial executive with a proven track record of effectively managing and expanding brand portfolios to accelerate growth and improve access for patients to important medications,” said Ketan Mehta, founder and CEO at Tris Pharma. “In his time at Tris Pharma, Manesh has consistently demonstrated remarkable leadership in inspiring and unifying teams to deliver excellence and high performance as we collectively advance our mission to improve patient lives.'.

Tris Pharma创始人兼首席执行官科坦·梅塔（KetanMehta）表示：“马内什是一位受人尊敬的领导者和经验丰富的商业高管，在有效管理和扩大品牌组合以加速增长和改善患者获得重要药物方面有着良好的业绩记录。”。“在Tris Pharma任职期间，马内什一直表现出卓越的领导力，在激励和团结团队以实现卓越和高绩效的同时，我们共同推进改善患者生活的使命。”。

In his new role, Mr. Naidu will lead the commercial strategy behind Tris Pharma’s ADHD portfolio to further strengthen its growth and success. His responsibilities will include leading marketing efforts for the Company’s approved medications, business development, sales strategy, market access and pricing, and product lifecycle management..

在新的职位上，奈杜先生将领导Tris Pharma ADHD投资组合背后的商业战略，以进一步加强其增长和成功。他的职责将包括领导公司批准药物的营销工作、业务发展、销售战略、市场准入和定价以及产品生命周期管理。。

Before joining Tris Pharma in 2023, Mr. Naidu was the chief marketing officer at Althera Pharmaceutical where he led all marketing functions for the company. Mr. Naidu started his career at McKinsey & Co. and has previously held various commercial leadership positions at Mallinckrodt (formerly Ikaria Inc.), Novartis, Pfizer and Bellerophon Therapeutics where he worked in a range of functions across several therapeutic areas.

在2023年加入Tris Pharma之前，Naidu先生是Althera Pharmaceutical的首席营销官，负责公司的所有营销职能。Naidu先生在麦肯锡公司开始了他的职业生涯，之前曾在Mallinckrodt（前Ikaria Inc.）、诺华、辉瑞和Bellerophon Therapeutics担任过多个商业领导职位，他在多个治疗领域从事一系列职能。

Mr. Naidu received his Bachelor of Engineering in Chemical Engineering and Master of Science in Chemistry from the Birla Institute of Technology and Science in Pilani, India, a Master of Science in Chemical Engineering from Oklahoma State University and a Master of Business Administration from the Kellogg School of Management at Northwestern University..

Naidu先生拥有印度皮拉尼Birla技术与科学研究所的化学工程学士和化学理学硕士学位，俄克拉荷马州立大学化学工程硕士学位，西北大学凯洛格管理学院工商管理硕士学位。。

“I feel privileged to take on the role of chief commercial officer at a pivotal time for Tris Pharma when we’re growing our portfolio of leading ADHD medications and generating new data highlighting the value of our products and unique delivery technology,” said Mr. Naidu. “As we continue our impressive track-record of delivering innovative solutions, I remain focused on expanding patient access to our therapies, broadening our product offerings and strengthening our partnerships.

奈杜先生说：“我很荣幸在Tris Pharma的关键时刻担任首席商务官，我们正在扩大领先的ADHD药物组合，并产生新的数据，突出我们产品的价值和独特的交付技术。”。“随着我们在提供创新解决方案方面取得令人印象深刻的成绩，我仍然专注于扩大患者获得我们治疗的机会，扩大我们的产品范围并加强我们的合作伙伴关系。

Together with our talented and passionate team, I’m committed to ensuring that our work ultimately has a meaningful impact on the patients, caregivers and healthcare providers we serve.”.

我与我们才华横溢、充满激情的团队一起，致力于确保我们的工作最终对我们服务的患者、护理人员和医疗保健提供者产生有意义的影响。”。

About Tris Pharma

关于Tris Pharma

Tris Pharma is a privately held, innovation-driven biopharmaceutical company that is applying its drug development capabilities and proprietary technologies to transform the treatment of ADHD, pain and neurological disorders, including addiction and diseases of the central nervous system. Tris is an established commercial organization with a robust portfolio of best-in-class ADHD products and a promising pipeline of differentiated, near-term drug candidates.

。Tris是一家成熟的商业组织，拥有一流的ADHD产品的强大组合，以及有前途的差异化近期候选药物渠道。

More information is available at www.trispharma.com and on LinkedIn @TrisPharma..

更多信息请访问www.trispharma.com和LinkedIn@trispharma。。